Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Deborah Ford

University College London

United Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United Kingdom Professors in Biostatistics Biostatistics professors in United Kingdom

Articles (10)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Collaborators (12)

Paul Revill

Professor and Head of Global Health Team

University of York

UNITED KINGDOM

View details

Elizabeth Chappell

University College London

UNITED KINGDOM

View details

Ronald Tonui

Lecturer

Moi University

View details

Trinh Duong

University College London

UNITED KINGDOM

View details

Srini Bandi

Cosultant Paediatrician

University Hospitals of Leicester NHS Trust

UNITED KINGDOM

View details

Ian White

Professor at Institute of Clinical Trials and Methodology (ICTM)

University College London

UNITED KINGDOM

View details

Janet Seeley

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

Rebecca Turner

University College London

UNITED KINGDOM

View details

Carlo Giaquinto

Docenti di ruolo di Ia fascia

University of Padova

ITALY

View details

Sarah Bernays

University of Sydney

UNITED KINGDOM

View details

Annabelle South

University College London

UNITED KINGDOM

View details

Eleni Nastouli

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Deborah Ford

Research Interests

Make your next move.

Explore related searches

Articles (10)

Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

Pathways of onward HIV disclosure in relationships among young people living with vertically acquired HIV receiving antiretroviral therapy: A qualitative analysis from the BREATHER Plus trial, South Africa

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial

Bayesian analysis in confirmatory clinical trials: A narrative review and discussion of current practice.

Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial

Adolescents in phase 3 HIV clinical trials

Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

Collaborators (12)

Paul Revill

Elizabeth Chappell

Ronald Tonui

Trinh Duong

Srini Bandi

Ian White

Janet Seeley

Rebecca Turner

Carlo Giaquinto

Sarah Bernays

Annabelle South

Eleni Nastouli

Make your next move.